Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Prevention trials

Topic: Risk, prevention and care in population studies

Data on 214 251 respondents were included in the study. We observed some variation in the prevalence and patterns (by age, gender, and education) of risk factors between HICs and LMICs. For example, low education had higher prevalence in many LMICs (85·6% [95% CI 84·8-86·5] in China vs 12·0% [95% CI 11·3-12·7] in the US), whereas obesity was more prevalent in HICs than in LMICs (44·9% [95% CI 43·3-46·5] in the US vs 13·3% [95% CI 12·9-13·7] in India). Risk factor distributions differed by age group, gender, and education, although patterns were not consistent across all settings. Risk factors commonly co-occurred across settings, with more than 50% of individuals having at least two risk factors across all countries and regions. Moreover, broadly similar clusters of risk factors-related to cardiovascular diseases, risky behaviours, and social or sensory factors-were observed across settings. Differences in the prevalence and patterns of dementia risk factors highlight the need to tailor prevention strategies to specific contexts. However, findings also reveal consistent patterns in risk factor co-occurrence and clustering, which could guide the design of multidomain interventions and policy approaches to reduce dementia risk across settings. Overall, these findings support the use of both context-specific and shared approaches to reduce the burden of dementia. FUNDING: National Institutes of Health.

Key findings

Why it matters

This cross-national analysis found differences in the prevalence and patterns of dementia risk factors across 14 countries and regions. It supports tailoring prevention strategies to context, but it did not test whether any intervention reduces dementia.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 1 of 4; Study design 4 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 0 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 2 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 43 of 100.43 of 100 points earned57 not earned

Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (The Lancet Healthy Longevity)
Journal's citation record 1 / 4 The Lancet Healthy Longevity: journal h-index 78 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 1 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.5 citations a year over 2 year(s) since 2026
Impact for its field and year 3 / 6 Cited 4.7× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author Jinkook Lee: h-index 48 (OpenAlex, whole career)
Institution's track record 2 / 3 Johns Hopkins University: institution h-index 2,306 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42437564)
Free to read 2 / 2 Free to read
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

APA 7th

Nichols, E. L., Kunicki, Z. J., Markot, M., Phillips, D. F., Wilkens, J., Gross, A. L., et al. (2026). Differences in the prevalence and patterns of dementia risk factors across 14 countries and regions: a harmonised cross-national analysis. The Lancet Healthy Longevity. https://doi.org/10.1016/j.lanhl.2026.100867

Vancouver

Nichols EL, Kunicki ZJ, Markot M, Phillips DF, Wilkens J, Gross AL, et al. Differences in the prevalence and patterns of dementia risk factors across 14 countries and regions: a harmonised cross-national analysis. The Lancet Healthy Longevity. 2026. doi:10.1016/j.lanhl.2026.100867. PMID: 42437564.

BibTeX

@article{nichols2026-42437564,
  author  = {Nichols, Emma L. and Kunicki, Zachary J. and Markot, Michael and Phillips, Drystan F. and Wilkens, Jenny and Gross, Alden L. and Lee, Jinkook},
  title   = {{Differences in the prevalence and patterns of dementia risk factors across 14 countries and regions: a harmonised cross-national analysis}},
  journal = {The Lancet Healthy Longevity},
  year    = {2026},
  doi     = {10.1016/j.lanhl.2026.100867},
  pmid    = {42437564},
  url     = {https://doi.org/10.1016/j.lanhl.2026.100867}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Prevention trials

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

Similar studies

More on Prevention trials

See all studies in Prevention trials →